SSKN (STRATA Skin Sciences, Inc.) Total Debt to Capital

Public company logo of strataskinsciences.com (SSKN)

The debt-to-equity ratio dynamics for STRATA Skin Sciences (SSKN) stand at 12.31. The company's position is bolstered by long-term leases of laser systems in medical centers, which creates high switching costs for practitioners. In-house manufacturing facilities in Pennsylvania ensure a consistent supply of components. Revenue is driven by per-session payments for XTRAC, fostering a strong dependency of clinics on these skin treatment technologies.

SSKN: STRATA Skin Debt to Capital 07/04/2022 - 02/21/2026
Finished products of STRATA Skin Sciences Inc.

To scale its network of psoriasis and vitiligo treatment equipment, STRATA Skin Sciences (SSKN) may utilize debt financing, which impacts its balance sheet structure. This metric compares total liabilities to net assets, determining the business's degree of reliance on external funding and its overall financial stability. By analyzing the debt-to-equity ratio, an investor assesses the balance between bankruptcy risks and the efficiency of leverage utilization.

Competitors of STRATA Skin Sciences

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio iridex.com IRIX|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Total Debt to Capital Beyond Air Inc XAIR|PFSA - Debt to Equity|GCTK: Debt to Equity|NAOV (NanoVibronix) - Total Debt to Equity Ratio|Venus Concept Corporation - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.